These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

580 related items for PubMed ID: 18713506

  • 1. Risk factors for multidrug-resistant tuberculosis in Hong Kong.
    Law WS, Yew WW, Chiu Leung C, Kam KM, Tam CM, Chan CK, Leung CC.
    Int J Tuberc Lung Dis; 2008 Sep; 12(9):1065-70. PubMed ID: 18713506
    [Abstract] [Full Text] [Related]

  • 2. TB surveillance in correctional institutions in Hong Kong, 1999-2005.
    Wong MY, Leung CC, Tam CM, Kam KM, Ma CH, Au KF.
    Int J Tuberc Lung Dis; 2008 Jan; 12(1):93-8. PubMed ID: 18173884
    [Abstract] [Full Text] [Related]

  • 3. Drug-resistant tuberculosis in six hospitals in Rio de Janeiro, Brazil.
    Brito RC, Mello FC, Andrade MK, Oliveira H, Costa W, Matos HJ, Lourenço MC, Rolla VC, Fonseca L, Ruffino Netto A, Kritski AL.
    Int J Tuberc Lung Dis; 2010 Jan; 14(1):24-33. PubMed ID: 20003691
    [Abstract] [Full Text] [Related]

  • 4. Infection and disease among household contacts of patients with multidrug-resistant tuberculosis.
    Teixeira L, Perkins MD, Johnson JL, Keller R, Palaci M, do Valle Dettoni V, Canedo Rocha LM, Debanne S, Talbot E, Dietze R.
    Int J Tuberc Lung Dis; 2001 Apr; 5(4):321-8. PubMed ID: 11334250
    [Abstract] [Full Text] [Related]

  • 5. Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis.
    Kim HR, Hwang SS, Kim HJ, Lee SM, Yoo CG, Kim YW, Han SK, Shim YS, Yim JJ.
    Clin Infect Dis; 2007 Nov 15; 45(10):1290-5. PubMed ID: 17968823
    [Abstract] [Full Text] [Related]

  • 6. Risk factors for multidrug-resistant tuberculosis in four centers in Burkina Faso, West Africa.
    Diandé S, Sangaré L, Kouanda S, Dingtoumda BI, Mourfou A, Ouédraogo F, Sawadogo I, Nébié B, Gueye A, Sawadogo LT, Traoré AS.
    Microb Drug Resist; 2009 Sep 15; 15(3):217-21. PubMed ID: 19728781
    [Abstract] [Full Text] [Related]

  • 7. Predictors and mortality associated with treatment default in pulmonary tuberculosis.
    Kliiman K, Altraja A.
    Int J Tuberc Lung Dis; 2010 Apr 15; 14(4):454-63. PubMed ID: 20202304
    [Abstract] [Full Text] [Related]

  • 8. Risk factors and outcome of human immunodeficiency virus-infected patients with sporadic multidrug-resistant tuberculosis in New York City.
    Mannheimer SB, Sepkowitz KA, Stoeckle M, Friedman CR, Hafner A, Riley LW.
    Int J Tuberc Lung Dis; 1997 Aug 15; 1(4):319-25. PubMed ID: 9432387
    [Abstract] [Full Text] [Related]

  • 9. Prevalence of multi-drug resistant tuberculosis in Karachi, Pakistan: identification of at risk groups.
    Ejaz M, Siddiqui AR, Rafiq Y, Malik F, Channa A, Mangi R, Habib F, Hasan R.
    Trans R Soc Trop Med Hyg; 2010 Aug 15; 104(8):511-7. PubMed ID: 20427065
    [Abstract] [Full Text] [Related]

  • 10. Risk factors for multidrug-resistant tuberculosis in Diyarbakir, Turkey.
    Tanrikulu AC, Abakay A, Abakay O.
    Med Sci Monit; 2010 Jun 15; 16(6):PH57-62. PubMed ID: 20512101
    [Abstract] [Full Text] [Related]

  • 11. Prevalence of drug-resistant tuberculosis in an HIV endemic area in northern Thailand.
    Yoshiyama T, Supawitkul S, Kunyanone N, Riengthong D, Yanai H, Abe C, Ishikawa N, Akarasewi P, Payanandana V, Mori T.
    Int J Tuberc Lung Dis; 2001 Jan 15; 5(1):32-9. PubMed ID: 11263513
    [Abstract] [Full Text] [Related]

  • 12. A retrospective study of human immunodeficiency virus infection and drug-resistant tuberculosis in Durban, South Africa.
    Anastasis D, Pillai G, Rambiritch V, Abdool Karim SS.
    Int J Tuberc Lung Dis; 1997 Jun 15; 1(3):220-4. PubMed ID: 9432367
    [Abstract] [Full Text] [Related]

  • 13. Determinants of drug-resistant tuberculosis: analysis of 11 countries.
    Espinal MA, Laserson K, Camacho M, Fusheng Z, Kim SJ, Tlali RE, Smith I, Suarez P, Antunes ML, George AG, Martin-Casabona N, Simelane P, Weyer K, Binkin N, Raviglione MC.
    Int J Tuberc Lung Dis; 2001 Oct 15; 5(10):887-93. PubMed ID: 11605880
    [Abstract] [Full Text] [Related]

  • 14. Management of multidrug-resistant tuberculosis in Italy.
    Ferrara G, Richeldi L, Bugiani M, Cirillo D, Besozzi G, Nutini S, Casali L, Fiorentini F, Codecasa LR, Migliori GB.
    Int J Tuberc Lung Dis; 2005 May 15; 9(5):507-13. PubMed ID: 15875921
    [Abstract] [Full Text] [Related]

  • 15. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Kwon YS, Kim YH, Suh GY, Chung MP, Kim H, Kwon OJ, Choi YS, Kim K, Kim J, Shim YM, Koh WJ.
    Clin Infect Dis; 2008 Aug 15; 47(4):496-502. PubMed ID: 18611154
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A population-based study of drug resistance and transmission of tuberculosis in an urban community.
    Telles MA, Ferrazoli L, Waldman EA, Giampaglia CM, Martins MC, Ueki SY, Chimara E, Silva CA, Cruz V, Waldman CC, Heyn I, Hirono IU, Riley LW.
    Int J Tuberc Lung Dis; 2005 Sep 15; 9(9):970-6. PubMed ID: 16158889
    [Abstract] [Full Text] [Related]

  • 18. Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus.
    Kam KM, Yip CW.
    Int J Tuberc Lung Dis; 2004 Jun 15; 8(6):760-6. PubMed ID: 15182147
    [Abstract] [Full Text] [Related]

  • 19. Tuberculosis risk factors in a silicotic cohort in Hong Kong.
    Chang KC, Leung CC, Tam CM.
    Int J Tuberc Lung Dis; 2001 Feb 15; 5(2):177-84. PubMed ID: 11258512
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.